Stocks
FibroGen (FGEN) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -141.8% | -201.0% | -652.1% | -480.8% | -712.7% | -612.2% | ||
| Changes by years, y/y, % | -49pp | -59pp | -451pp | +171pp | -232pp | +50.2% | |||
FibroGen. EBITDA margin, %
FibroGen. EBITDA margin, changes, pp
FibroGen (FGEN) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -856.5% | -1 010% | -728.8% | 0.19% | -1 192% | -612.2% | |
| Changes by years, y/y, % | +3 715pp | -984pp | -655pp | +518pp | -336pp | |||
| Changes by quarters, q/q, % | -339pp | -154pp | +282pp | +729pp | -1 192pp | |||
